Cariprazine，又称卡利拉嗪，是可口服的D2/D3多巴胺受体拮抗剂，是一种抗精神病药物，用于精神分裂和双相Ⅰ型情感障碍的治疗。

参考文献

[1] Kiss B, Horváth A, Némethy Z, et al. Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. J Pharmacol Exp Ther. 2010 Apr;333(1):328-40. doi: 10.1124/jpet.109.160432(IF:3.615).

[2] Seneca N, Finnema SJ, Laszlovszky I, et al. Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography. Psychopharmacology (Berl). 2011 Dec;218(3):579-87. doi: 10.1007/s00213-011-2343-z(IF:3.424).

-25~-15℃保存，有效期3年。